Literature DB >> 21499787

Social interaction and drug attitude effectiveness in patients with schizophrenia.

Jui-Kang Tsai1, Wen-Kuo Lin, For-Wey Lung.   

Abstract

This study aimed to explore the relationship between dosage of paliperidone and drug attitude, and also clarify the factors associated with drug attitude, using Intention-to-Treat (ITT) analysis. Three hundred thirty-one patients diagnosed with schizophrenia, who prescribed paliperidone between April 2008 and April 2009, from 10 hospitals in Taiwan were enrolled. By structural equation modeling, inpatient/outpatient status associated with occupation status, sex, and score on the Clinical Global Impression-Severity (CGIS) Scale. The score on the Personal and Social Performance (PSP) Scale associated with occupation status, inpatient/outpatient status, and the score on the CGIS Scale. The scores on the DAI-10 associated with the score on the PSP Scale and age. Good drug attitude and medication adherence significantly related to good social interaction. We should enhance the drug attitude and medication adherence of patients with schizophrenia who have poor social interaction to improve the outcome of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499787     DOI: 10.1007/s11126-011-9177-z

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  33 in total

Review 1.  What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors:  S Hollis; F Campbell
Journal:  BMJ       Date:  1999-09-11

2.  Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.

Authors:  A Hofer; M A Rettenbacher; M Edlinger; G Kemmler; C G Widschwendter; W W Fleischhacker
Journal:  Acta Psychiatr Scand       Date:  2007-09-14       Impact factor: 6.392

3.  Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.

Authors:  J Garavan; S Browne; M Gervin; A Lane; C Larkin; E O'Callaghan
Journal:  Compr Psychiatry       Date:  1998 Jul-Aug       Impact factor: 3.735

4.  Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.

Authors:  Jennifer C Day; Richard P Bentall; Chris Roberts; Fiona Randall; Anne Rogers; Dinah Cattell; David Healy; Pam Rae; Cheryl Power
Journal:  Arch Gen Psychiatry       Date:  2005-07

5.  [Factors related to treatment adherence in schizophrenic patients].

Authors:  I García Cabeza; E I Sánchez Díaz; M Sanz Amador; M Gutiérrez Rodríguez; M González de Chávez
Journal:  Actas Esp Psiquiatr       Date:  1999 Jul-Aug       Impact factor: 1.196

6.  Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

Authors:  M Lambert; J M Haro; D Novick; E T Edgell; L Kennedy; M Ratcliffe; D Naber
Journal:  Acta Psychiatr Scand       Date:  2005-03       Impact factor: 6.392

7.  Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up.

Authors:  G Dunn; M Maracy; C Dowrick; J L Ayuso-Mateos; O S Dalgard; H Page; V Lehtinen; P Casey; C Wilkinson; J L Vazquez-Barquero; G Wilkinson
Journal:  Br J Psychiatry       Date:  2003-10       Impact factor: 9.319

8.  One-year outcome of schizophrenic patients--the interaction of chronicity and neuroleptic treatment.

Authors:  W Gaebel; A Pietzcker
Journal:  Pharmacopsychiatry       Date:  1985-05       Impact factor: 5.788

9.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

10.  Attitude towards adherence in patients with schizophrenia at discharge.

Authors:  Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Journal:  J Psychiatr Res       Date:  2009-06-07       Impact factor: 4.791

View more
  5 in total

1.  Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Authors:  Kun-Po Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2017-12

2.  Correlates of Negative Attitudes towards Medication in People with Schizophrenia.

Authors:  Lucie Kondrátová; Daniel König; Karolína Mladá; Petr Winkler
Journal:  Psychiatr Q       Date:  2019-03

Review 3.  The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

4.  Factors Affecting Well-being and Socio-occupational Functioning in Schizophrenia Patients Following an Acute Exacerbation: A Hospital Based Observational Study.

Authors:  Roopa Gopalakrishnan; Rishikesh V Behere; P S V N Sharma
Journal:  Indian J Psychol Med       Date:  2015 Oct-Dec

Review 5.  Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review.

Authors:  LiLi Zhang; JiTao Li; YanJie Zhao; Yun'Ai Su; Tianmei Si
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-11       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.